Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Peters

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Gerontology|March 1, 1978
Organizational position and perceptions of problems in a nursing homeD C Hughes, G R Peters
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1997
Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/dayJ C Fleishaker, G R Peters
Journal of Clinical Pharmacology|September 1, 1996
Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazadJ C Fleishaker, G R Peters
Topics in Health Care Financing|January 1, 1994
Tax exemption and integrated delivery systemsW J Aseltyne, G R Peters
The Journal of Antimicrobial Chemotherapy|April 1, 1989
The effects of cefmetazole and latamoxef on platelet function in healthy human volunteersG R Peters, C M Metzler
The Healthcare Forum Journal|August 7, 1989
Where to venture next? After some relatively smooth sailing, hospital-physician joint ventures face turbulent timesG R Peters, R B Carpenter
The Gerontologist|February 1, 1982
When priests retireM A Kaiser, G R Peters, N Babchuk
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteersJ C Fleishaker, L K Hulst, G R Peters
Journal of Clinical Pharmacology|February 1, 1993
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administrationJ C Fleishaker, G R Peters, K S Cathcart
Journal of Pharmaceutical Sciences|March 1, 1995
Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A inductionJ C Fleishaker, L K Pearson, G R Peters
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Gerontology|March 1, 1978
Organizational position and perceptions of problems in a nursing homeD C Hughes, G R Peters
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1997
Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/dayJ C Fleishaker, G R Peters
Journal of Clinical Pharmacology|September 1, 1996
Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazadJ C Fleishaker, G R Peters
Topics in Health Care Financing|January 1, 1994
Tax exemption and integrated delivery systemsW J Aseltyne, G R Peters
The Journal of Antimicrobial Chemotherapy|April 1, 1989
The effects of cefmetazole and latamoxef on platelet function in healthy human volunteersG R Peters, C M Metzler
The Healthcare Forum Journal|August 7, 1989
Where to venture next? After some relatively smooth sailing, hospital-physician joint ventures face turbulent timesG R Peters, R B Carpenter
The Gerontologist|February 1, 1982
When priests retireM A Kaiser, G R Peters, N Babchuk
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteersJ C Fleishaker, L K Hulst, G R Peters
Journal of Clinical Pharmacology|February 1, 1993
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administrationJ C Fleishaker, G R Peters, K S Cathcart
Journal of Pharmaceutical Sciences|March 1, 1995
Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A inductionJ C Fleishaker, L K Pearson, G R Peters
Pageof 6